Invention Grant
US07959907B2 Method of treating cancer by combination therapy using TNF and alpha-galactosylceramide
失效
使用TNF和α-半乳糖神经酰胺联合治疗癌症的方法
- Patent Title: Method of treating cancer by combination therapy using TNF and alpha-galactosylceramide
- Patent Title (中): 使用TNF和α-半乳糖神经酰胺联合治疗癌症的方法
-
Application No.: US12449652Application Date: 2008-02-20
-
Publication No.: US07959907B2Publication Date: 2011-06-14
- Inventor: Peter Brouckaert , Dirk Elewaut , Leander Huyghe
- Applicant: Peter Brouckaert , Dirk Elewaut , Leander Huyghe
- Applicant Address: BE Gent BE Gent
- Assignee: VIB VZW,Universiteit Gent
- Current Assignee: VIB VZW,Universiteit Gent
- Current Assignee Address: BE Gent BE Gent
- Agency: TraskBritt, P.C.
- Priority: EP07102787 20070221
- International Application: PCT/EP2008/052055 WO 20080220
- International Announcement: WO2008/101951 WO 20080828
- Main IPC: A61K45/00
- IPC: A61K45/00 ; A61K31/00 ; A61K38/00 ; A01N61/00
Abstract:
The invention relates to the treatment of cancer. More specifically the invention shows that the anti-cancer activity in mammals can be augmented by administering to the mammalian host a combination of a synergistically effective amount of TNF and alfa-galactosylceramide.
Public/Granted literature
- US20100166697A1 COMBINATION THERAPY USING TNF AND ALFA-GALACTOSYL CERAMIDE Public/Granted day:2010-07-01
Information query
